Immune-related targets

Immune-related targets" refers collectively to all molecular entities that play roles in modulating or regulating the immune system. This includes receptors like PD-1 and CTLA4, enzymes such as JAK kinases, cytokines like interleukins and interferons, transcription factors involved in lymphocyte function, cell surface antigens recognized by antibodies or engineered T cells, among others. These diverse molecules are central both as biomarkers and direct therapeutic intervention points across cancer immunotherapy, autoimmune diseases treatment strategies, infectious disease management, transplantation medicine and more. Because this phrase does not specify any particular gene product or protein structure—and instead encompasses hundreds of distinct validated druggable entities—it cannot be mapped directly onto structured data fields intended for individual molecular drug targets.

Other names

Immune modulatory targetsImmunotherapy targetsImmune checkpoint moleculesImmunomodulatory proteins

Varies widely depending on the specific target. Examples include: Blocking inhibitory checkpoints to enhance T cell activity (checkpoint inhibitors); Modulating cytokine signaling pathways; Suppressing lymphocyte activation/proliferation.